Martin Williams Email & Phone Number

Advising companies on development of a business model and strategy for various areas including:Fractional Advisory / Independent Board Director Roles - Fractional executive and academic spin-out / equity financing strategy for synthetic bioengineered platform - Board director for novel neuromodulation approach - Regulatory advisory and FDA strategy for digital health company in neurological care management and behavioral intervention - Commercialization and corporate strategy for novel physical assistive device academic spin-out - Strategic advisor for novel pediatric epilepsy remote monitoring solutionPrivate Equity Diligence and Operating Partner - Diligence and US-market entry strategy for private equity transaction of European healthcare entities in the neurological and rehabilitation space

Cambridge, Ma, Us

Employee number two and key executive leadership for spinout from MIT lab discovery. Ownership of multiple roles throughout tenure involving:- product development strategy and execution, - clinical study strategy and execution, - marketing strategy and - corporate strategy / business development. Successfully showed the safety, feasibility and clinical promise of novel neurostimulation for Alzheimer's disease in over 40,000 at-home treatment sessions in hundreds of patients via multiple Ph1/2 studies. After positioning Cognito to enter pivotal studies (2023), I left to develop a new company.

Kalamazoo, Mi, Us

Global franchise management for intracranial atherosclerosis treatment devices (ICAD), a form of stroke more prevalent in Asian populations.Spearheaded new product development efforts, KOL management and clinical study design and regulatory strategy for new platform devices.Performed clinician training, concentrating in China, Japan, Korea and Hong Kong.

Murray Hill, New Jersey, Us

M&A diligence - start-up to large capAcquisition - NASDAQ:ROCM ($262M)Three year strategic planning for $850M divisionGlobal VOC assessments

TIF finds promising medical technologies in their earliest stages and leads them to market via new companies.Supported discussions with multiple strategic acquirers for the sale of a novel dermatology therapeutic Developed a commercialization strategy model and proposal for introducing a venture-backed start-up medical device in GermanyClinical and strategic analysis of emphysema and dermatology companies Led the technical due diligence for multiple investment and incubator candidatesContributed to technical development of medical devices in response to clinical data and investor/strategic feedback

Minneapolis, Mn, Us

Global market leader in brain monitoring solutions (BIS Technology) which are used to measure the depth of consciousness during surgery. Lead engineer for disposable sensor production factory which produced 7MM sensors annually, representing $85MM in sales. Responsibilities spanned all phases of production engineering: design-for-manufacture, plant layout, machine design

U.S. Genomics was a start-up biotech firm developing a novel bio-security machine for Homeland Security’s Advanced Research Projects Agency to "sniff" the air for anthrax and other bioterror agents.Led the design and assembly of multiple components on a lab analytics machine including a centrifuge rotor indexer, robotic syringe pump, and fluidic transfer plumbing.Developed a DNA shearing device to facilitate a novel approach to cutting long strands of DNA into consistent lengths

Mba, Entrepreneurship, Marketing

Bs, Manufacturing Engineering